General Information
Drug ID
DR00136
Drug Name
Regorafenib
Synonyms
24T2A1DOYB; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide; 4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide; BAY-73-4506; BAY73-4506; BAY73-4506 hydrochloride; CHEBI:68647; CHEMBL1946170; Regorafenib (BAY 73-4506); Regorafenib [USAN:INN]; Regorafenibum; Stivarga; Stivarga (TN); UNII-24T2A1DOYB
Drug Type
Small molecular drug
Indication Metastatic colorectal cancer [ICD11: 2B91] Approved [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=11167602"></iframe>
3D MOL 2D MOL
Formula
C21H15ClF4N4O3
Canonical SMILES
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F
InChI
InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
InChIKey
FNHKPVJBJVTLMP-UHFFFAOYSA-N
CAS Number
CAS 755037-03-7
Pharmaceutical Properties Molecular Weight 482.82 Topological Polar Surface Area 92.4
Heavy Atom Count 33 Rotatable Bond Count 5
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 8
PubChem CID
11167602
PubChem SID
123055398 , 124757057 , 124772081 , 125163861 , 126731249 , 131480720 , 135261819 , 135626856 , 135727382 , 136367351 , 136368060 , 136920288 , 136937804 , 136967459 , 137245314 , 137275982 , 142611634 , 144115687 , 152090526 , 152258021 , 152258178 , 152344131 , 160645781 , 160647014 , 162011543 , 162037486 , 16247148 , 163698233 , 164041884 , 164764796 , 172087026 , 172093559 , 174530361 , 175267155 , 175427139 , 178102514 , 186014501 , 188899566 , 198992717 , 223381220 , 223498454 , 223565986 , 223680722 , 223704854 , 223925935 , 226756197 , 23360295 , 42222352 , 75430857 , 99437016
ChEBI ID
ChEBI:68647
TTD Drug ID
D09GDD
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [3]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [3]
P-GP Transporter Info P-glycoprotein 1 Substrate [4]
References
1 Regorafenib was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01913)
3 Regorafenib is transported by the organic anion transporter 1B1 and the multidrug resistance protein 2. Biol Pharm Bull. 2015;38(4):582-6.
4 Brain and Testis Accumulation of Regorafenib is Restricted by Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1). Pharm Res. 2015 Jul;32(7):2205-16.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.